114 related articles for article (PubMed ID: 36882345)
1. Sigmoid dose accumulation and reporting for multifractionated brachytherapy for cervical cancer: Methodological development of sigmoid points through virtual endoscopic method.
Bindal A; Mittal P; Shinghal A; Scaria L; Prajapati K; Swamidas J; Gurram L; Berger D; Sturdza A; Chopra S
Brachytherapy; 2023; 22(3):325-333. PubMed ID: 36882345
[TBL] [Abstract][Full Text] [Related]
2. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
Hung J; Shen S; De Los Santos JF; Kim RY
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
[TBL] [Abstract][Full Text] [Related]
3. A knowledge-based organ dose prediction tool for brachytherapy treatment planning of patients with cervical cancer.
Yusufaly TI; Kallis K; Simon A; Mayadev J; Yashar CM; Einck JP; Mell LK; Brown D; Scanderbeg D; Hild SJ; Covele B; Moore KL; Meyers SM
Brachytherapy; 2020; 19(5):624-634. PubMed ID: 32513446
[TBL] [Abstract][Full Text] [Related]
4. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
[TBL] [Abstract][Full Text] [Related]
5. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
[TBL] [Abstract][Full Text] [Related]
6. Bladder distension improves the dosimetry of organs at risk during intracavitary cervical high-dose-rate brachytherapy.
Harmon G; Chinsky B; Surucu M; Harkenrider M; Small W
Brachytherapy; 2016; 15(1):30-4. PubMed ID: 26521661
[TBL] [Abstract][Full Text] [Related]
7. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
[TBL] [Abstract][Full Text] [Related]
8. Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator position.
Nkiwane KS; Pötter R; Fokdal LU; Hoskin P; Pearcey R; Segedin B; Mahantshetty U; Kirisits C
Brachytherapy; 2015; 14(2):252-9. PubMed ID: 25530424
[TBL] [Abstract][Full Text] [Related]
9. Effects of bladder distension on organs at risk in 3D image-based planning of intracavitary brachytherapy for cervical cancer.
Kim RY; Shen S; Lin HY; Spencer SA; De Los Santos J
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):485-9. PubMed ID: 19467797
[TBL] [Abstract][Full Text] [Related]
10. Additional rectal and sigmoid mucosal points and doses in high dose rate intracavitary brachytherapy for carcinoma cervix: a dosimetric study.
Mahantshetty U; Tiwana MS; Jamema S; Mishra S; Engineer R; Deshpande D; Shrivastava S
J Cancer Res Ther; 2011; 7(3):298-303. PubMed ID: 22044811
[TBL] [Abstract][Full Text] [Related]
11. Point A vs. HR-CTV D
Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
[TBL] [Abstract][Full Text] [Related]
12. Sigmoid dose using 3D imaging in cervical-cancer brachytherapy.
Holloway CL; Racine ML; Cormack RA; O'Farrell DA; Viswanathan AN
Radiother Oncol; 2009 Nov; 93(2):307-10. PubMed ID: 19665244
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L
Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371
[TBL] [Abstract][Full Text] [Related]
14. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
15. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
16. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional dose accumulation in pseudo-split-field IMRT and brachytherapy for locally advanced cervical cancer.
Sun B; Yang D; Esthappan J; Garcia-Ramirez J; Price S; Mutic S; Schwarz JK; Grigsby PW; Tanderup K
Brachytherapy; 2015; 14(4):481-9. PubMed ID: 25958039
[TBL] [Abstract][Full Text] [Related]
18. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
[TBL] [Abstract][Full Text] [Related]
19. Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel.
Kim RY; Shen S; Duan J
Brachytherapy; 2007; 6(3):187-94. PubMed ID: 17606413
[TBL] [Abstract][Full Text] [Related]
20. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.
Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ
Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
